ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Moderna (MRNA)
Moderna stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$198.85▼ -0.62%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
42%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Moderna in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Moderna
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Moderna a 42% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $149.77 and $232.93; in 9 out of 10, between $101.25 and $344.54. Estimated annual volatility is 143%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $76.8B
- 52-week high
- $254.48
- 52-week low
- $22.28
- Revenue (12 months)
- $2.2B
- Revenue growth (YoY)
- -39.9%
- Gross margin
- 54.8%
- Operating margin
- -159.9%
- Net margin
- -146.8%
- Return on equity
- -39.0%
- Free cash flow (12 months)
- $299M
- Beta
- 1.11
What this means
ATLAS does not publish a fair value for MRNA right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks MRNA has traded between $22.28 and $254.48. Today it is 21.9% below that high and 793% above its low.
On the business: revenue fell 39.9% year over year; net margin is 146.8%.
Its beta is 1.11: it moves roughly in line with the market.
About the company
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology.
Want to see everything about Moderna?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Moderna do?
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology.
What is the chance MRNA goes up next month?
42%: somewhat worse than a coin flip. In half of the simulated outcomes, MRNA ends the month between $149.77 and $232.93.
How big is Moderna and what is its P/E ratio?
Moderna's market capitalization is $76.8B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is MRNA?
ATLAS estimates annual volatility at 143%. In a typical month, half of the outcomes end between $149.77 and $232.93.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer